FDA Import Refusal 799-4477512-1/11/1 — AbbVie Inc.

AbbVie Inc. — FEI 1411365

The FDA refused shipment 799-4477512-1/11/1 from AbbVie Inc. (United States) on April 20, 2023. The refused product falls under Drugs and Biologics — BOTOX. Cited charges: 118,3280 This firm has 5 or more other import refusals on record.

Refusal Details

Date
April 20, 2023
Country
United States
Product Category
Drugs and Biologics
Product Code
65QCY02 BOTOX
Charges
118,3280